Cargando…
BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
BACKGROUND: Accurate diagnosis and prognostication of intra-axial brain tumors hinges on invasive brain sampling, which carries risk of morbidity. Minimally invasive sampling of proximal fluids, also known as liquid biopsy, can mitigate this risk. Although the cerebrospinal fluid (CSF) is the ideal...
Autores principales: | Mansouri, Alireza, Mikolajewicz, Nicholas, Khan, Shahbaz, Glantz, Michael, Moffat, Jason, Zadeh, Gelareh, Kislinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354165/ http://dx.doi.org/10.1093/noajnl/vdac078.002 |
Ejemplares similares
-
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies
por: Mikolajewicz, Nicholas, et al.
Publicado: (2022) -
BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022) -
BSCI-21 COX4I1 EXPRESSION IN BRAIN METASTASES
por: Saad, Mahak, et al.
Publicado: (2022) -
BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
por: Zhu, Lucía, et al.
Publicado: (2021) -
BSCI-13. MTH1 expression is upregulated in brain metastases of malignant melanoma
por: Timmer, Marco
Publicado: (2021)